A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.
Clinical trial NCT02607306 · COMPLETED
Trial details
- NCT number
- NCT02607306
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-18
- Primary completion
- 2017-12-15
- Enrollment
- 819
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.